MedPath

Tobramycin and Dexamethasone

Tobramycin and Dexamethasone Ophthalmic Suspension USP, 0.3%/0.1% (Sterile)

Approved
Approval ID

0e460787-5413-44d3-bd60-69d3d04f97eb

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Oct 6, 2010

Manufacturers
FDA

Physicians Total Care, Inc.

DUNS: 194123980

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Tobramycin and Dexamethasone

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code54868-6286
Application NumberANDA064134
Product Classification
M
Marketing Category
C73584
G
Generic Name
Tobramycin and Dexamethasone
Product Specifications
Route of AdministrationOPHTHALMIC
Effective DateAugust 10, 2011
FDA Product Classification

INGREDIENTS (2)

DEXAMETHASONEActive
Quantity: 1 mg in 1 mL
Code: 7S5I7G3JQL
Classification: ACTIB
TOBRAMYCINActive
Quantity: 3 mg in 1 mL
Code: VZ8RRZ51VK
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Tobramycin and Dexamethasone - FDA Drug Approval Details